Poultry Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (Broiler, Layer, Breeder), By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines), By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others), By Region and Competition, 2020-2030F

Market Overview

Global Poultry Vaccines Market has valued at USD 1.89 Billion in 2024 and is expected to reach USD 2.78 Billion by 2030 with a CAGR of 6.64% during the forecast period. The Global Poultry Vaccines Market is a dynamic and essential segment of the global animal healthcare industry. This market primarily revolves around the development, production, and distribution of vaccines designed to safeguard poultry, including chickens and turkeys, from a range of diseases. Poultry farming is a critical component of the global food supply chain, making the availability of effective vaccines crucial for maintaining the health and productivity of poultry flocks.

The demand for vaccinations is expected to increase due to the increasing popularity of chickens. The number of zoonotic cases has led to an increase in demand for poultry vaccinations. For example, according to a report by the World Health organization, a government institution with headquarters in the United States, the number of zoonotic cases in Africa increased by 64% in 2022.

The increasing prevalence of Infectious Bursal Disease (IBD) is a major driver of growth in the poultry vaccines market. IBD is a highly contagious viral disease that primarily affects young chickens, leading to immunosuppression, heightened vulnerability to secondary infections, and elevated mortality rates. This growing threat has amplified the demand for effective vaccination strategies to protect poultry health, minimize economic losses, and enhance overall productivity. For example, a cross-sectional study highlighted in a September 2024 article by the National Library of Medicine examined the seroprevalence and risk factors of IBD between October 2020 and June 2021. The findings revealed an overall seroprevalence rate of 47%, with 361 serum samples testing positive for the disease. The prevalence varied across regions, with Didessa reporting 55.9%, Chora at 43.3%, and Gechi at 41.2%. These figures underscore the critical need for widespread vaccination to control the spread and impact of IBD.

Key Market Drivers

Rising Global Poultry Consumption

The global poultry industry is soaring to new heights, fueled by an ever-increasing global demand for poultry products such as chicken and turkey. This growing appetite for poultry is not only a testament to shifting dietary preferences but also a major driver for the expansion of the global poultry vaccines market. Poultry, particularly chicken, has become a staple in diets worldwide due to its affordability, versatility, and lean protein content. As global populations burgeon and urbanization continues, the demand for poultry products has surged. According to industry reports, poultry consumption is on a steady upward trajectory, with no signs of slowing down. This surge in demand directly correlates with the need for a healthy and sustainable poultry industry. The poultry industry is not only a vital source of protein but also a significant contributor to the global economy. However, it is highly susceptible to disease outbreaks that can decimate poultry flocks, disrupt supply chains, and incur substantial economic losses. Diseases such as avian influenza, Newcastle disease, and coccidiosis pose constant threats to poultry farms. Consequently, safeguarding poultry health has become imperative for the industry's sustained growth. The International Journal of Current Microbiology and Applied Sciences (IJCMAS) report published in October 2021 reveals that total losses due to Newcastle disease mortality and total expenditure on live birds in all the 25 commercial broiler farms ranged between INR 17,864 (US$ 214.0) to INR 2,66,080 (US$ 3,188.89) and INR 2,78,393 (US$ 3,336.46) to INR 17,86,745 (US$ 21,413.6), respectively. Also, the selling income of live birds from individual farms ranged from INR 1,60,255 (US$ 1,920.61) to INR 12,46,314 (US$ 14,936.7) due to infection.

Poultry vaccines are a fundamental tool in preventing and managing disease outbreaks. They offer a cost-effective and humane way to protect poultry flocks from various diseases. By vaccinating birds, farmers can reduce the morbidity and mortality rates, ensuring a consistent and healthy supply of poultry products. The reliability of vaccines in preventing disease outbreaks is a driving force behind their increasing adoption in the poultry industry. As global poultry consumption continues to rise, poultry farmers and producers are becoming more conscious of the importance of disease prevention. To meet the growing demand for poultry products and mitigate the risk of disease outbreaks, farmers are increasingly implementing vaccination programs. These programs involve the administration of vaccines to poultry flocks at various stages of their lifecycle, bolstering their immunity and overall health. The surge in poultry consumption has prompted significant investments in research and development within the poultry vaccines industry. Companies are focusing on developing more efficacious and innovative vaccines to combat a broader spectrum of diseases. These advancements include novel vaccine formulations, improved delivery methods, and region-specific vaccines tailored to local disease profiles.

Preventing Disease Outbreaks in Poultry Animals

The global poultry industry is facing unprecedented challenges as it strives to meet the ever-growing demand for poultry products. Disease outbreaks in poultry flocks can be catastrophic, resulting in significant economic losses and disruptions to the supply chain. In response to this threat, the global poultry vaccines market has emerged as a crucial player in safeguarding poultry health. Poultry, including chickens and turkeys, are highly susceptible to a range of diseases, including avian influenza, Newcastle disease, infectious bronchitis, and coccidiosis. These diseases can spread rapidly within flocks, leading to increased mortality rates, decreased production efficiency, and substantial financial losses for poultry farmers. Preventing these diseases is paramount to ensuring the health and productivity of poultry animals. Poultry vaccines are pivotal tools in preventing and managing disease outbreaks in poultry populations. These vaccines are specifically formulated to stimulate the bird's immune system, equipping them to fend off pathogens. By vaccinating poultry animals, farmers can reduce the risk of disease transmission and minimize the impact of outbreaks, resulting in healthier flocks and a more reliable supply of poultry products.

The economic ramifications of disease outbreaks in poultry are profound. Losses can encompass not only the direct costs of bird mortality but also the expenses associated with disease control measures, such as increased medication usage, quarantine procedures, and additional labor costs. Moreover, the disruption in the supply chain can lead to price fluctuations and reduced availability of poultry products in the market. Farmers and poultry producers are increasingly recognizing the value of vaccination programs in preventing disease outbreaks. These programs involve the systematic administration of vaccines to poultry flocks at various stages of their lifecycle. As awareness of the importance of disease prevention grows, more farmers are investing in vaccination programs as a proactive strategy to protect their investments and ensure a consistent supply of poultry products. The global poultry industry is expanding, particularly in emerging markets where urbanization, rising incomes, and changing dietary habits are driving increased poultry consumption. As the poultry industry grows, so does the need for effective disease prevention strategies. Poultry vaccines are an integral part of these strategies, contributing to the overall health and sustainability of the industry.

Advancements in Vaccine Technology

The global poultry vaccines market is undergoing a significant transformation, driven in large part by groundbreaking advancements in vaccine technology. Poultry farming, a cornerstone of the food industry, faces ever-increasing challenges from disease outbreaks and the need to meet the world's growing demand for poultry products. One of the most notable benefits of advancements in vaccine technology is the enhanced efficacy of poultry vaccines. Traditional vaccines have given way to more sophisticated formulations that can provide longer-lasting protection with fewer doses. These next-generation vaccines stimulate a stronger and more sustained immune response in poultry, reducing the likelihood of disease outbreaks and improving overall flock health. Modern vaccine technology allows for the development of highly specific vaccines tailored to target particular diseases or strains of pathogens.

This level of precision is essential in addressing the diverse range of diseases that affect poultry. By targeting specific pathogens, vaccines can offer better protection against a broader spectrum of diseases, including avian influenza, Newcastle disease, and coccidiosis. Advancements in vaccine delivery methods have made vaccination more convenient and efficient for poultry farmers. Traditional injection-based vaccines are being complemented by innovative approaches such as oral vaccines, aerosolized vaccines, and vaccine-laden bait. These methods simplify vaccine administration, reduce stress on birds, and minimize the need for skilled labor, contributing to cost savings and increased adoption rates. New vaccine technologies are designed to stimulate the bird's immune system more effectively. Adjuvants and delivery systems have been refined to trigger a robust and sustained immune response. This ensures that poultry develop strong immunity to diseases, resulting in fewer disease-related losses and more productive flocks. To address region-specific disease challenges, vaccine manufacturers are developing customized regional vaccines. These vaccines take into account the prevalent diseases and strains in a specific geographic area, providing poultry farmers with tailored solutions for their unique disease profiles. This customization allows for more effective disease prevention strategies.

Expanding Poultry Industry in Emerging Markets

The global poultry industry is experiencing a remarkable expansion, and much of this growth is driven by emerging markets in regions like Asia-Pacific, Latin America, and Africa. As these markets witness a surge in poultry production and consumption, the demand for effective disease prevention measures, particularly poultry vaccines, is on the rise. Emerging economies are becoming key players in the global poultry industry due to factors such as rapid urbanization, increasing disposable incomes, and changing dietary preferences. These regions are experiencing a shift towards a higher consumption of protein-rich poultry products like chicken and turkey. As a result, emerging markets are steadily emerging as major contributors to the global poultry industry.

The expanding poultry industry in emerging markets is characterized by substantial increases in poultry production. Poultry farms are growing in size and sophistication, adopting modern farming practices and technology. With the goal of meeting the rising demand for poultry products, these farms are managing larger flocks, which in turn increases the potential for disease outbreaks. The rapid growth of the poultry industry in emerging markets is accompanied by new and evolving disease challenges. Poultry diseases, such as avian influenza, Newcastle disease, and coccidiosis, pose significant threats to poultry health and production. These diseases can spread rapidly within densely populated poultry farms, leading to severe economic losses and potential food security concerns. Poultry vaccines are indispensable tools in preventing and managing disease outbreaks in poultry flocks. They offer a cost-effective and humane means of protecting poultry from a wide range of diseases. As emerging markets grapple with increased disease risks due to intensified poultry production, the importance of vaccines in maintaining flock health and securing food supplies cannot be overstated.

Download Free Sample Report

Key Market Challenges

Disease Complexity and Variability

One of the foremost challenges in the poultry vaccines market is the complexity and variability of poultry diseases. Poultry are susceptible to a wide range of pathogens, including viruses, bacteria, and parasites, each with different strains and mutations. Developing vaccines that provide comprehensive protection against these evolving pathogens can be a formidable task.

Regulatory Hurdles

The production and distribution of vaccines are subject to stringent regulatory requirements to ensure safety and efficacy. Meeting these regulatory standards can be a costly and time-consuming process for vaccine manufacturers. Any deviations from these standards can lead to delays in vaccine approval and market entry, increasing the financial burden.

Cold Chain Management

Maintaining the integrity of vaccines throughout the distribution process is critical. Poultry vaccines are often sensitive to temperature fluctuations, and improper storage can render them ineffective. In regions with limited infrastructure and resources, maintaining a reliable cold chain for vaccines can be a significant challenge.

Vaccine Resistance and Compliance

Vaccine resistance, where pathogens develop resistance to vaccines, is a growing concern. Additionally, ensuring that poultry farmers adhere to recommended vaccination schedules and protocols can be challenging. Inconsistent vaccine administration can lead to gaps in protection and disease outbreaks.

Key Market Trends

Precision Vaccination

Precision vaccination is a trend gaining momentum in the poultry vaccines market. This approach involves tailoring vaccination programs to the specific needs of individual flocks or poultry houses. By considering factors such as age, health status, and disease exposure, precision vaccination aims to optimize vaccine efficacy while minimizing costs. Advanced data analytics and monitoring systems are being employed to implement precision vaccination strategies effectively.

Immune-Boosting Adjuvants

Innovations in vaccine adjuvants are on the horizon. Adjuvants are substances added to vaccines to enhance the body's immune response. The development of novel adjuvants can improve the efficacy of poultry vaccines, enabling better protection against a wider range of diseases. These adjuvants may also reduce the need for multiple booster vaccinations, enhancing the convenience and cost-effectiveness of vaccination programs.

DNA Vaccines

DNA vaccines are gaining attention for their potential in the poultry vaccines market. These vaccines use genetic material (DNA) to stimulate the immune system. DNA vaccines are advantageous due to their safety, stability, and potential for rapid development. As research in this area progresses, DNA vaccines may become a viable alternative to traditional vaccines for poultry diseases.

Vaccine Delivery Innovations

Advancements in vaccine delivery systems are set to revolutionize the poultry vaccines market. In addition to traditional injection-based vaccines, novel delivery methods such as oral vaccines, aerosolized vaccines, and vaccine-laden bait are being developed. These methods simplify vaccine administration, reduce stress on birds, and increase the efficiency of vaccination programs.

Segmental Insights

Disease Type Insights

Based on Disease Type, Salmonella category held the largest revenue share in the poultry vaccines market. This dominance is primarily due to the widespread prevalence and economic impact of Salmonella infections in poultry, which pose significant threats not only to animal health but also to public health through contaminated poultry products. The disease can lead to reduced productivity, increased mortality, and major financial losses for poultry farmers. To mitigate these risks, there has been a strong focus on the development and adoption of effective Salmonella vaccines. Regulatory bodies and food safety authorities across various countries have also implemented stringent guidelines to control Salmonella outbreaks, further driving the demand for targeted vaccination. Additionally, consumer awareness regarding foodborne illnesses has led to increased pressure on producers to ensure biosecure farming practices, where Salmonella vaccination plays a key role. As a result, this category continues to command a significant portion of market revenues. Market participants are actively engaged in research and development efforts to introduce new vaccines, aiming to expand their presence and market share. For instance, Venkys India offers a range of poultry vaccines, including the Salmonella polyvalent inactivated vaccine, designed to prevent and manage salmonellosis in layers, breeders, and broilers. KM Biologics includes OILVAX EDS-76 in its portfolio, which effectively combats egg drop syndrome.

Download Free Sample Report

Regional Insights

Based on Region, North America held the largest revenue share in the poultry vaccines market. This dominance can be attributed to the region’s well-established poultry industry, high awareness regarding animal health, and strong regulatory framework supporting disease prevention through vaccination. Additionally, advanced veterinary infrastructure and the presence of major pharmaceutical and biotechnology companies in the U.S. and Canada contribute significantly to market growth. The high consumption of poultry products in North America also plays a crucial role in driving vaccine demand, as producers strive to maintain flock health and ensure food safety. Moreover, government initiatives and funding toward controlling zoonotic diseases and enhancing food security further boost vaccine adoption. Continuous innovation and research in vaccine development, including recombinant and vector-based vaccines, also solidify North America’s leading position in the global poultry vaccines market. For instance, in October 2024, Boehringer Ingelheim revealed that the United States Department of Agriculture (USDA) issued a permit for the import of its TUR-3 vaccine, which targets Newcastle disease, avian paramyxovirosis type 3, and turkey rhinotracheitis with a killed virus formulation. Thus, such initiatives adopted by the market players will lead to enhanced product availability in the market, further driving market growth.

In the North America poultry vaccines market, the United States plays a pivotal role due to its large-scale commercial poultry industry and proactive disease management initiatives. For instance, data released by the United States Department of Agriculture (USDA) in November 2024 revealed that H5 detections occurred in 50 commercial poultry flocks and 38 backyard flocks, affecting approximately 25.61 million birds across the country. This underscores the vulnerability of large poultry operations to avian diseases and highlights the critical need for effective vaccination strategies. Consequently, commercial poultry farms emerge as key end users in the region, given their expansive operations and heightened focus on productivity and biosecurity, thereby significantly driving the growth of the poultry vaccines market in North America.

Recent Developments

• In November 2024, Boehringer Ingelheim, a leading biopharmaceutical company, launched a next-generation vaccine for Marek's disease in chickens in India, aiming to enhance poultry health and disease prevention in the region.
• In October 2024, the U.S. Department of Agriculture (USDA) approved a vaccine targeting avian metapneumovirus (aMPV) subtype B for use in commercial turkey and chicken flocks. While countries outside the U.S. have long utilized both live and inactivated vaccines to combat aMPV in poultry, this marks a significant step for the U.S. market. The National Turkey Federation had previously urged the USDA to allow the import of vaccines for avian metapneumovirus to better protect domestic poultry flocks.
• In October 2024, Vaxxinova announced that the Committee for Medicinal Products for Veterinary Use (CVMP) had issued a positive opinion recommending the approval of Vaxxon ND Clone in the European Union. This vaccine is intended for the active immunization of chickens—including broilers, future layers, and breeders—to reduce mortality rates and mitigate clinical symptoms caused by Newcastle disease virus infections.
• In July 2024, the U.S. Department of Health and Human Services (HHS), through its Biomedical Advanced Research and Development Authority (BARDA), awarded Moderna USD 176 million to develop a pre-pandemic vaccine for H5 avian influenza. The goal is to combat the H5N1 avian flu in poultry using Moderna’s domestic large-scale mRNA vaccine manufacturing infrastructure, which also supports the development of mRNA-based seasonal influenza vaccines.
• In May 2024, researchers at the University of Nebraska Medical Center reported that an experimental mRNA vaccine targeting the H5N1 avian flu demonstrated strong effectiveness in protecting laboratory animals from severe illness and death. This vaccine holds promise for addressing the ongoing H5N1 outbreaks impacting wild birds and poultry across the U.S.
• In April 2024, Merck Animal Health announced that the Committee for Veterinary Medicinal Products (CVMP) of the European Medicines Agency had issued a favorable opinion for its INNOVAX-ND-H5 vaccine, designed for use in chickens. This approval paves the way for the vaccine’s marketing authorization in the EU.
• In January 2020, Boehringer Ingelheim introduced the VAXXITEK HVT+IBD+ND vaccine to safeguard poultry from Newcastle Disease, Marek's Disease, and Infectious Bursal Disease, encompassing both classic and variant strains.
• In July of 2019, Ceva completed the acquisition of IDT Biologika GmbH's veterinary biopharmaceutical division and research and development operations.

Key Market Players

• Boehringer Ingelheim GmbH
• Zoetis Inc
• Elanco LLC
• Intervet Inc
• Hester Biosciences Ltd
• Vaxxinova GmbH
• Venky's India Ltd
• Laboratorios Calier SA
• KM Biologics Co Ltd
• Phibro Animal Health Corporation

Report Scope:

In this report, the Global Poultry Vaccines Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Poultry Vaccines Market, By Application:

o   Broiler

o   Layer

o   Breeder

• Poultry Vaccines Market, By Product:

o   Attenuated Live Vaccines

o   Inactivated Vaccines

o   Subunit Vaccines

o   DNA Vaccines

o   Recombinant Vaccines

• Poultry Vaccines Market, By Disease Type:

o   Infectious Bronchitis

o   Infectious Bursal Diseases

o   Infectious Laryngotracheitis

o   Egg Drop Syndrome

o   Adenovirus

o   Duck Viral Enteritis

o   Inclusion Body Hepatitis

o   Salmonella

o   Others

• Poultry Vaccines Market, By Region:

o   North America

§  United States

§  Mexico

§  Canada

o   Europe

§  France

§  Germany

§  United Kingdom

§  Italy

§  Spain

o   Asia-Pacific

§  China

§  India

§  South Korea

§  Japan

§  Australia

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East and Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Poultry Vaccines Market.

Available Customizations:

Global Poultry Vaccines market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Poultry Vaccines Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us sales@techsciresearch.com